Xero (XRO) H1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY27 revenue was NZ$1,745.3m, up 46% reported and 27% pro forma; adjusted EBITDA reached NZ$361.6m and pro forma free cash flow rose 32%.
Customer additions, higher ARPC, payments growth and product adoption supported performance; FY27 revenue and adjusted EBITDA guidance increased.
FY27 pro forma Rule of 40 is expected at ~40%, a year ahead of the prior aspiration; FY28 revenue aspiration rose above NZ$4.6bn, excluding synergies.
An on-market buy-back of up to A$1bn was approved; Melio-related margin and profit pressure continued.
Financial highlights
Operating revenue was NZ$1,745.3m, up 46% reported and 41% in constant currency; pro forma growth was 27%, or 22% in constant currency.
Adjusted EBITDA was NZ$361.6m, up 3% reported and 23% pro forma; reported EBITDA was NZ$347.5m and EBIT was NZ$109.9m.
Pro forma free cash flow rose 32% to NZ$238.1m; reported free cash flow fell 26% to NZ$238.1m, partly reflecting Melio inclusion.
Pro forma gross profit increased 22% to NZ$1,327m; pro forma gross margin declined 3.1 percentage points to 76.0%, mainly from Melio payment mix.
Net profit fell 86% to NZ$18.5m, reflecting Melio’s incorporation and the non-recurrence of prior-year foreign-exchange gains on term deposits.
Outlook and guidance
FY27 revenue guidance increased to NZ$3.77bn–NZ$3.83bn from NZ$3.62bn–NZ$3.73bn; pro forma constant-currency growth is expected at 24%–27%.
FY27 adjusted EBITDA guidance is NZ$880m–NZ$920m, raised from a prior NZ$860m–NZ$920m range; H2 is expected to carry higher-than-historical weighting.
FY27 pro forma Rule of 40 is expected at ~40%; FY28 revenue aspiration is above NZ$4.6bn excluding revenue synergies, with Rule of 40 above 40%.
Melio is expected to reach adjusted EBITDA breakeven on a run-rate basis in H2 FY28; NZ$70m of revenue synergies are expected in FY28.
FY27 D&A is estimated at NZ$475m; product capitalisation rates are expected within the long-term 40%–45% range.
Latest events from Xero
- Strong revenue growth, US expansion, and AI innovation amid governance and shareholder scrutiny.XRO
AGM 2026 - 31% revenue growth and 18% EBITDA rise, led by US, Melio, and AI innovation, support strong FY27 outlook.XRO
H2 2026 - AI and Melio integration drive US growth, efficiency, and profitability, with FY26 guidance reaffirmed.XRO
Investor update - 20% revenue growth, 42% higher net profit, and Melio integration fuel robust expansion.XRO
H1 2026 - Robust growth, strategic US expansion, and AI innovation drive future ambitions, with key votes passed.XRO
AGM 2025 - US$2.5b acquisition integrates payments and accounting, triples ARPU, and targets major synergies.XRO
M&A Announcement - Revenue up 25%, EBITDA up 52%, and net profit up 76%, with strong subscriber and ARPU growth.XRO
H1 2025 - Strong growth, new strategy, and high AGM approval marked the year.XRO
AGM 2024 - Revenue up 23%, EBITDA up 22%, Rule of 40 at 44.3, with strong global growth and innovation.XRO
H2 2025